Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical trial outcomes for SLE: what we have and what we need.
Arnaud L, Parodis I, Devilliers H, Chasset F. Arnaud L, et al. Among authors: parodis i. Lupus Sci Med. 2024 Feb 15;11(1):e001114. doi: 10.1136/lupus-2023-001114. Lupus Sci Med. 2024. PMID: 38360028 Free PMC article. Review.
Gender differences in patient experience in idiopathic inflammatory myopathies: Sub analysis from the COVAD dataset.
Yoshida A, Kim M, Kuwana M, Ravichandran N, Makol A, Sen P, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Joshi M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, Nikiphorou E, Chatterjee T, Tan AL, Nune A, Cavagna L, Saavedra MA, Shinjo SK, Ziade N, Knitza J, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L. Yoshida A, et al. Among authors: parodis i. Mod Rheumatol. 2023 Sep 28:road094. doi: 10.1093/mr/road094. Online ahead of print. Mod Rheumatol. 2023. PMID: 37769200
Smoking reduces the efficacy of belimumab in mucocutaneous lupus.
Parodis I, Gomez A, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I. Parodis I, et al. Expert Opin Biol Ther. 2018 Aug;18(8):911-920. doi: 10.1080/14712598.2018.1494719. Epub 2018 Jul 9. Expert Opin Biol Ther. 2018. PMID: 29958508 Free article.
Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.
Parodis I, Emamikia S, Gomez A, Gunnarsson I, van Vollenhoven RF, Chatzidionysiou K. Parodis I, et al. Expert Opin Biol Ther. 2019 Feb;19(2):157-168. doi: 10.1080/14712598.2019.1561856. Epub 2018 Dec 27. Expert Opin Biol Ther. 2019. PMID: 30571926 Clinical Trial.
B cell alterations during BAFF inhibition with belimumab in SLE.
Ramsköld D, Parodis I, Lakshmikanth T, Sippl N, Khademi M, Chen Y, Zickert A, Mikeš J, Achour A, Amara K, Piehl F, Brodin P, Gunnarsson I, Malmström V. Ramsköld D, et al. Among authors: parodis i. EBioMedicine. 2019 Feb;40:517-527. doi: 10.1016/j.ebiom.2018.12.035. Epub 2018 Dec 26. EBioMedicine. 2019. PMID: 30593436 Free PMC article.
130 results